Group 1 - The core viewpoint of the news is the significant rise in A-share market stocks related to brain-computer interface concepts, with notable increases in several companies' stock prices [1] - Among the companies, Botao Bio surged over 12%, Innovation Medical reached a daily limit up (5 consecutive days), Sanbo Brain Science increased over 9%, Nanjing Panda rose over 4%, Qisheng Technology gained over 3%, and Aipeng Medical went up over 2% [1] - Innovation Medical announced its investment in Bole Brain-Computer (Hangzhou) Technology Co., Ltd., holding a 40% stake, which focuses on the research and development of core brain-computer interface technologies and related product design for medical rehabilitation [1] Group 2 - As of the announcement date, Bole Brain-Computer's products have not officially launched, with only a small quantity sold through collaborations with research institutions [1] - The projected operating losses for Bole Brain-Computer are 6.60 million yuan in 2023 and 8.66 million yuan in 2024 [1]
A股异动丨脑机接口概念股继续走强,创新医疗8天5板